We are live on ! Find out more
HUMA icon

Humacyte
HUMA

61 hedge funds and large institutions have $69M invested in Humacyte in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 9

178% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $964K

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

91% more funds holding

Funds holding: 32 → 61 (+29)

2.26% more ownership

Funds ownership: 6.99% → 9.25% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $77.5M → $69M (-$8.53M)

Holders
61
Holders Change
+29
Holders Change %
+90.63%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
10
Reduced
5
Closed
9
Calls
$2.68M
Puts
$964K
Net Calls
+$1.71M
Net Calls Change
-$779K

Top Buyers

1
BlackRock
BlackRock
New York
+$13.9M
2
UOC
UBS O'Connor
Illinois
+$8.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.69M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.67M
5
Charles Schwab
Charles Schwab
California
+$2.91M

Top Sellers

1
O
OrbiMed
New York
-$17.4M
2
DCP
Diameter Capital Partners
New York
-$6.47M
3
CH
CVI Holdings
Delaware
-$5.8M
4
MIM
Monashee Investment Management
Massachusetts
-$3.46M
5
MS
Maven Securities
Jersey
-$2.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
YCMGA
1
York Capital Management Global Advisors
New York
$16.6M – – –
BlackRock
2
BlackRock
New York
$10.2M +$13.9M +1,401,073 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$8.47M +$8.69M +878,123 +303%
UOC
4
UBS O'Connor
Illinois
$6.53M +$8.9M +900,100 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$4.38M +$5.67M +573,380 +1,854%
MIM
6
Monashee Investment Management
Massachusetts
$2.9M -$3.46M -350,090 -47%
DCP
7
Diameter Capital Partners
New York
$2.18M -$6.47M -653,800 -69%
Charles Schwab
8
Charles Schwab
California
$2.13M +$2.91M +294,240 New
GIA
9
Gladstone Institutional Advisory
Florida
$1.79M +$2.44M +246,717 New
UBS Group
10
UBS Group
Switzerland
$1.75M +$2.38M +240,596 +30,925%
LPL Financial
11
LPL Financial
California
$1.73M +$1.23M +124,250 +108%
MS
12
Maven Securities
Jersey
$1.45M -$2.97M -300,000 -60%
Northern Trust
13
Northern Trust
Illinois
$901K +$1.23M +124,376 New
Swiss National Bank
14
Swiss National Bank
Switzerland
$822K +$1.12M +113,400 New
EWM
15
Endowment Wealth Management
Wisconsin
$700K +$956K +96,618 New
CSS
16
Cubist Systematic Strategies
Connecticut
$680K +$928K +93,785 New
Morgan Stanley
17
Morgan Stanley
New York
$666K +$193K +19,474 +27%
PGP
18
Prescott General Partners
Florida
$580K +$791K +80,000 New
Goldman Sachs
19
Goldman Sachs
New York
$563K +$768K +77,685 New
State Street
20
State Street
Massachusetts
$505K +$689K +69,677 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$317K +$433K +43,779 New
LP
22
LMR Partners
United Kingdom
$268K +$366K +36,960 New
CS
23
Credit Suisse
Switzerland
$255K +$348K +35,148 New
Two Sigma Investments
24
Two Sigma Investments
New York
$225K +$307K +31,061 New
CP
25
CenterBook Partners
Connecticut
$172K +$234K +23,706 New
1
2 3

HUMA Hedge Fund Activity: Q4 2021 in Review

61 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q4 2021, worth a combined $69M — down 11% from $77.5M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new HUMA positions and 9 closed out — a net gain of 30 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $13.9M. The largest seller was OrbiMed, exiting entirely with an estimated $17.4M sold.

  • 61 institutional investors held Humacyte (HUMA) as of Q4 2021, up from 32 in Q3 2021.
  • Funds reported $69M of Humacyte stock for Q4 2021, down 11% quarter-over-quarter.
  • 39 funds opened new Humacyte positions in Q4 2021 and 9 closed out, a net change of +30 holders.
  • The largest Humacyte buyer in Q4 2021 was BlackRock, an estimated $13.9M added.
  • The largest Humacyte seller in Q4 2021 was OrbiMed, an estimated $17.4M sold.

Based on aggregated 13F filings for Q4 2021.